Benefit from prolonged dose-intensive chemotherapy for infants with malignant brain tumors is restricted to patients with ependymoma: a report of the Pediatric Oncology Group randomized controlled trial 9233/34
Douglas Strother(Women & Children's Hospital of Buffalo), Amar Gajjar(St. Jude Children's Research Hospital), Patricia A. Aronin(Women & Children's Hospital of Buffalo), Lucie Lafay‐Cousin(Women & Children's Hospital of Buffalo), P. C. Burger(University of Zurich), J. M. Boyett(Women & Children's Hospital of Buffalo), L. Kun(Radiation Oncology Associates), Marc E. Horowitz(National Cancer Institute), Mehmet Koçak(St. Jude Children's Research Hospital), Patricia K. Duffner(Buffalo State University), L.S. Constine(Women & Children's Hospital of Buffalo)
Cited by 81
Related Papers
Novel mutations target distinct subgroups of medulloblastoma
|Nature|2012|853
Integrated Molecular Genetic Profiling of Pediatric High-Grade Gliomas Reveals Key Differences With the Adult Disease
|Journal of Clinical Oncology|2010|657
Risk stratification of childhood medulloblastoma in the molecular era: the current consensus
|Acta Neuropathologica|2016|650
Improved outcome in childhood acute lymphoblastic leukaemia with reinforced early treatment and rotational combination chemotherapy
|The Lancet|1991|387
Second malignancies after Ewing's sarcoma: radiation dose-dependency of secondary sarcomas.
|Journal of Clinical Oncology|1996|353